Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years

Weigang Gu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9671-5371; OpenAlex author ID A5042100861. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 2 papers

Papers 3

  1. Hyperthermia improves gemcitabine sensitivity of pancreatic cancer cells by suppressing the EFNA4/β-catenin axis and activating dCK. Co-author DOI 10.1016/j.heliyon.2024.e28488↗
  2. Global research trends and hotspots between pancreatic cancer and diabetes from2004 to 2024: A bibliometric analysis Co-author DOI 10.21203/rs.3.rs-4198735/v1↗
  3. The Role of Feedback Loops in Targeted Therapy for Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.800140↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaofeng Zhang · 3 shared papers, 2022–2024 · strength 0.66
  2. Hangbin Jin · 2 shared papers, 2024 · strength 0.46
  3. Hongzhang Shen · 2 shared papers, 2022–2024 · strength 0.43
  4. Qiaoxian He · 1 shared paper, 2024 · strength 0.23
  5. Yuxin Wang · 1 shared paper, 2024 · strength 0.23
  6. Jianfeng Yang · 1 shared paper, 2022 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.